Table of Content

1. Executive Summary
   1.1. Global Generic Oncology Drugs Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Disease Epidemiology - Cancer Statistics
   3.3. Patent Expiration Analysis & Pipeline Analysis
   3.4. Recent Product Launches and Approvals Insights
   3.5. Generic and Biosimilar - Comparative Analysis
   3.6. Regulatory Landscape
   3.7. Promotional Strategies, By Key Players
   3.8. Porter’s Five Force Analysis
   3.9. PESTLE Analysis
4. Global Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Global Generic Oncology Drugs Market Outlook: Molecule
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Molecule, 2019 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
           4.3.3.1. Large Molecule
           4.3.3.2. Small Molecule
       4.3.4. Market Attractiveness Analysis: Molecule
   4.4. Global Generic Oncology Drugs Market Outlook: Route of Administration
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019 - 2022
       4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
           4.4.3.1. Oral
           4.4.3.2. Parenteral
       4.4.4. Market Attractiveness Analysis: Route of Administration
   4.5. Global Generic Oncology Drugs Market Outlook: Distribution Channel
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
           4.5.3.1. Hospital Pharmacies
           4.5.3.2. Retail Pharmacies
           4.5.3.3. Online Pharmacies
       4.5.4. Market Attractiveness Analysis: Distribution Channel
5. Global Generic Oncology Drugs Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       6.2.1. By Country
       6.2.2. By Molecule
       6.2.3. By Route of Administration
       6.2.4. By Distribution Channel
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       6.4.1. Large Molecule
       6.4.2. Small Molecule
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       6.5.1. Oral
       6.5.2. Parenteral
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       6.6.1. Hospital Pharmacies
       6.6.2. Retail Pharmacies
       6.6.3. Online Pharmacies
   6.7. Market Attractiveness Analysis
7. Europe Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       7.2.1. By Country
       7.2.2. By Molecule
       7.2.3. By Route of Administration
       7.2.4. By Distribution Channel
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       7.4.1. Large Molecule
       7.4.2. Small Molecule
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       7.5.1. Oral
       7.5.2. Parenteral
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       7.6.1. Hospital Pharmacies
       7.6.2. Retail Pharmacies
       7.6.3. Online Pharmacies
   7.7. Market Attractiveness Analysis
8. East Asia Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       8.2.1. By Country
       8.2.2. By Molecule
       8.2.3. By Route of Administration
       8.2.4. By Distribution Channel
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       8.4.1. Large Molecule
       8.4.2. Small Molecule
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       8.5.1. Oral
       8.5.2. Parenteral
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       8.6.1. Hospital Pharmacies
       8.6.2. Retail Pharmacies
       8.6.3. Online Pharmacies
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       9.2.1. By Country
       9.2.2. By Molecule
       9.2.3. By Route of Administration
       9.2.4. By Distribution Channel
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       9.4.1. Large Molecule
       9.4.2. Small Molecule
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       9.5.1. Oral
       9.5.2. Parenteral
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       9.6.1. Hospital Pharmacies
       9.6.2. Retail Pharmacies
       9.6.3. Online Pharmacies
   9.7. Market Attractiveness Analysis
10. Latin America Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       10.2.1. By Country
       10.2.2. By Molecule
       10.2.3. By Route of Administration
       10.2.4. By Distribution Channel
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       10.4.1. Large Molecule
       10.4.2. Small Molecule
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       10.5.1. Oral
       10.5.2. Parenteral
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       10.6.1. Hospital Pharmacies
       10.6.2. Retail Pharmacies
       10.6.3. Online Pharmacies
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Generic Oncology Drugs Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       11.2.1. By Country
       11.2.2. By Molecule
       11.2.3. By Route of Administration
       11.2.4. By Distribution Channel
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. South Africa
       11.3.3. Northern Africa
       11.3.4. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2023 - 2031
       11.4.1. Large Molecule
       11.4.2. Small Molecule
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       11.5.1. Oral
       11.5.2. Parenteral
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       11.6.1. Hospital Pharmacies
       11.6.2. Retail Pharmacies
       11.6.3. Online Pharmacies
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Teva Pharmaceutical Industries Ltd.
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Mylan N.V. (Viatris)
       12.3.3. Sandoz Group AG
       12.3.4. Fresenius Kabi AG
       12.3.5. Apotex Inc.
       12.3.6. Zydus Cadila
       12.3.7. Hikma Pharmaceuticals
       12.3.8. Sun Pharmaceutical Industries Ltd.
       12.3.9. Cipla Limited
       12.3.10. Lupin Pharmaceuticals
       12.3.11. Pfizer Inc.
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations